{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:23:01Z","timestamp":1761708181351},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.dld.2007.11.029","type":"journal-article","created":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T12:50:36Z","timestamp":1201956636000},"page":"e4-e7","source":"Crossref","is-referenced-by-count":12,"title":["Antiphospholipid syndrome during pegylated interferon alpha-2a therapy for chronic hepatitis C"],"prefix":"10.1016","volume":"41","author":[{"given":"D.C.","family":"Balderramo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Colmenero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Forns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2007.11.029_bib1","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2007.11.029_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2141.1998.00722.x","article-title":"Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C","volume":"101","author":"Leroy","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.dld.2007.11.029_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2007.11.029_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.dld.2007.11.029_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00005792-200303000-00005","article-title":"Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients","volume":"82","author":"Espinosa","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.dld.2007.11.029_bib6","first-page":"447","article-title":"Extrahepatic manifestations in patients with chronic hepatitis C virus infection","volume":"17","author":"Ramos-Casals","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.dld.2007.11.029_bib7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0168-8278(99)80127-5","article-title":"Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome","volume":"30","author":"Munoz-Rodriguez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2007.11.029_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.510230201","article-title":"Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome","volume":"23","author":"Prieto","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2007.11.029_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s005350050345","article-title":"High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications","volume":"35","author":"Harada","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2007.11.029_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CDLI.7.2.241-244.2000","article-title":"Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome","volume":"7","author":"Ordi-Ros","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.dld.2007.11.029_bib11","first-page":"1138","article-title":"High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha","volume":"90","author":"Matsuda","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2007.11.029_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0168-8278(01)00024-1","article-title":"Development of lupic anticoagulant during combination therapy in a patient with chronic hepatitis C","volume":"34","author":"Carmona-Soria","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2007.11.029_bib13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1097-0142(19940315)73:6<1621::AID-CNCR2820730613>3.0.CO;2-E","article-title":"Antiphospholipid syndrome associated with immunotherapy for patients with melanoma","volume":"73","author":"Becker","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2007.11.029_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/sarh.2002.37277","article-title":"Autoimmune disease complicating antiviral therapy for hepatitis C virus infection","volume":"32","author":"Wilson","year":"2002","journal-title":"Semin Arthritis Rheum"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865807006792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865807006792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T12:55:46Z","timestamp":1588337746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865807006792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1590865807006792"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2007.11.029","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}